Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress - PubMed (original) (raw)
Review
Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress
D W Emery et al. Ann N Y Acad Sci. 1999.
Abstract
Virus vectors hold great promise for the stem cell gene therapy of beta-chain hemoglobinopathies. However, conventional vectors suffer from low gene transfer rates, low expression levels, and inconsistent or short-lived expression in vivo. In this review we summarize the current status of vector systems for the transduction of hematopoietic stem cells, including the development of novel vector systems and methods for selection of transduced stem cells in vivo. We also summarize efforts to achieve therapeutic expression levels of transferred globin genes with retrovirus vectors, including the manipulation of transcription cassettes, the use of globin gene enhancers, and advances in the use of chromatin insulators for improving the frequency of gene expression following hematopoietic stem cell transduction.
Similar articles
- Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo.
Emery DW, Yannaki E, Tubb J, Nishino T, Li Q, Stamatoyannopoulos G. Emery DW, et al. Blood. 2002 Sep 15;100(6):2012-9. doi: 10.1182/blood-2002-01-0219. Blood. 2002. PMID: 12200360 - Gene Therapy for Hemoglobinopathies.
Cavazzana M, Mavilio F. Cavazzana M, et al. Hum Gene Ther. 2018 Oct;29(10):1106-1113. doi: 10.1089/hum.2018.122. Hum Gene Ther. 2018. PMID: 30200783 Free PMC article. Review. - Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
Payen E, Leboulch P. Payen E, et al. Hematology Am Soc Hematol Educ Program. 2012;2012:276-83. doi: 10.1182/asheducation-2012.1.276. Hematology Am Soc Hematol Educ Program. 2012. PMID: 23233592 Review. - Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.
Bhukhai K, de Dreuzy E, Giorgi M, Colomb C, Negre O, Denaro M, Gillet-Legrand B, Cheuzeville J, Paulard A, Trebeden-Negre H, Borwornpinyo S, Sii-Felice K, Maouche L, Down JD, Leboulch P, Payen E. Bhukhai K, et al. Mol Ther. 2018 Feb 7;26(2):480-495. doi: 10.1016/j.ymthe.2017.10.015. Epub 2017 Oct 24. Mol Ther. 2018. PMID: 29221807 Free PMC article. - Gene Therapy Approaches to Hemoglobinopathies.
Ferrari G, Cavazzana M, Mavilio F. Ferrari G, et al. Hematol Oncol Clin North Am. 2017 Oct;31(5):835-852. doi: 10.1016/j.hoc.2017.06.010. Hematol Oncol Clin North Am. 2017. PMID: 28895851 Review.
Cited by
- Strategies to insulate lentiviral vector-expressed transgenes.
Ramezani A, Hawley RG. Ramezani A, et al. Methods Mol Biol. 2010;614:77-100. doi: 10.1007/978-1-60761-533-0_5. Methods Mol Biol. 2010. PMID: 20225037 Free PMC article. - Hematopoietic stem cell gene therapy.
Emery DW, Nishino T, Murata K, Fragkos M, Stamatoyannopoulos G. Emery DW, et al. Int J Hematol. 2002 Apr;75(3):228-36. doi: 10.1007/BF02982035. Int J Hematol. 2002. PMID: 11999349 Review. - A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
Shayakhmetov DM, Carlson CA, Stecher H, Li Q, Stamatoyannopoulos G, Lieber A. Shayakhmetov DM, et al. J Virol. 2002 Feb;76(3):1135-43. doi: 10.1128/jvi.76.3.1135-1143.2002. J Virol. 2002. PMID: 11773389 Free PMC article. - A chromatin insulator protects retrovirus vectors from chromosomal position effects.
Emery DW, Yannaki E, Tubb J, Stamatoyannopoulos G. Emery DW, et al. Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9150-5. doi: 10.1073/pnas.160159597. Proc Natl Acad Sci U S A. 2000. PMID: 10908661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical